INFLUENCE OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE POLYMORPHISM ON THE PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND IgA NEPHROPATHY

Background: The reason of variability of clinical course and progression to end-stage renal failure (ESRF) of two widespread chronic nephropathies—autosomal dominant polycystic kidney disease (ADPKD) and IgA nephropathy (IGAN) is not clear. The endothelial dysfunction is considered in the number of factors possibly influencing the prognosis of these nephropathies. Our study tried to verify the hypothesis that endothelial nitric oxide synthase (ecNOS) gene polymorphisms in intron 4 could have some relevance to the progression of ADPKD and/or IgA nephropathy. Methods: We examined 128 Czech patients with ADPKD (62 males, 66 females) and 93 patients with IGAN (51 males, 42 females). As a control group, we used 100 genetically unrelated healthy subjects (50 men, 50 women, mean age 51.2 ± 8.2). The genomic DNA was amplified by polymerase chain reaction (PCR) and the products were separated on 1.5% agarose gel and visualized by ultraviolet transillumination. We compared homozygous subjects for ecNOSb allele with homozygous and heterozygous subjects for ecNOSa allele. Results: The frequencies of ecNOSa/b + a/a and ecNOSb/b genotypes were 19% (19/100) and 81% (81/100) in the control group. The frequencies of ecNOSa/b + a/a and ecNOSb/b genotypes in ADPKD patients were: 26.6% (8/30) and 73.4% (22/30) in ADPKD patients with normal renal function, 30% (9/30) and 70% (21/30) in ADPKD with ESRF, 35.2% (18/51) and 64.8% (33/51) in young ADPKD patients, 60% (12/20) and 40% (8/20) in ADPKD patients with ESRF later than in 62 years. In IGAN, the frequencies of ecNOSa/b + a/a and ecNOSb/b genotypes were 24% (12/50) and 76% (38/50) in IgA with normal renal function and 20.9% (9/43) and 79.1% (38/43) in IgA with ESRF. Conclusion: Both in ADPKD and IGAN groups, there was no significant difference in the frequencies of ecNOS genotypes between patients with normal renal function and age matched patients with ESRF and between patients with normal renal function and control group. The frequency of ecNOSa allele was significantly higher in a number limited group ADPKD patients with ESRF later than in 62 years (Chi-square test p<0.05). This higher frequency of a allele among ADPKD patients with later onset of ESRF could suggest the trend of positive influence of a allele in ADPKD patients.

[1]  R. Torra,et al.  Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  S. Strandgaard,et al.  Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. , 2000, Journal of the American Society of Nephrology : JASN.

[3]  S. Kikuchi,et al.  Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseases. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  Dan Wang,et al.  Contractility and Endothelium-Dependent Relaxation of Resistance Vessels in Polycystic Kidney Disease Rats , 1999, Journal of Vascular Research.

[5]  T. Suehiro,et al.  Effect of a polymorphism of endothelial nitric oxide synthase gene in Japanese patients with IgA nephropathy. , 1999, Clinical nephrology.

[6]  C. Baylis,et al.  Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition. , 1999, Kidney international.

[7]  M. Goligorsky,et al.  Duality of nitric oxide in acute renal injury. , 1999, Seminars in nephrology.

[8]  W. Welch,et al.  Nitric oxide and tubuloglomerular feedback. , 1999, Seminars in nephrology.

[9]  Y. Kawaguchi,et al.  Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. , 1998, Biochemical and biophysical research communications.

[10]  M. Yokota,et al.  Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. , 1998, The American journal of cardiology.

[11]  V. Kliem,et al.  Gene-polymorphisms of angiotensin converting enzyme and endothelial nitric oxide synthase in patients with primary glomerulonephritis. , 1997, Clinical nephrology.

[12]  C. Baylis,et al.  Importance of nitric oxide in the control of renal hemodynamics. , 1996, Kidney international.

[13]  J. Garvin,et al.  Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. , 1995, Journal of the American Society of Nephrology : JASN.

[14]  A. Woolf,et al.  Taxol inhibits progression of congenital polycystic kidney disease , 1994, Nature.

[15]  A. Deng,et al.  Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. , 1992, The Journal of clinical investigation.

[16]  A. Hartner,et al.  J Am Soc Nephrol 11: 71–79, 2000 Nitric Oxide Synthase Isoforms and Glomerular Hyperfiltration in Early Diabetic Nephropathy , 2022 .

[17]  W. Beierwaltes,et al.  Evolution of chronic nitric oxide inhibition hypertension: relationship to renal function. , 1998, Hypertension.

[18]  J. Garvin,et al.  Nitric oxide inhibits ADH-stimulated osmotic water permeability in cortical collecting ducts. , 1996, The American journal of physiology.

[19]  R. Badenhop,et al.  A smoking–dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene , 1996, Nature Medicine.